May 15, 202442 words
Published: May 15, 2024 | 42 words
Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share some groundbreaking news. The U.S. Food and Drug Administration (FDA) has given its approval for the Investigational New Drug application for PEX010, Filament Health's botanical psilocybin drug candida...
CRITIC REVIEWS
There don't seem to be any reviews yet.
PUBLIC REVIEWS
There don't seem to be any reviews yet.